These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 21362225)

  • 1. [Relationship between expression of chemokine receptor and curative effect of multiple myeloma].
    Pei RZ; Tang SH; Ma JX; Zhang PS; Liu XH; DU XH; Chen Z; Chen D; Sha KY; Cao JJ; Li SY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):73-5. PubMed ID: 21362225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of chemokine receptor (CCR1, CCR2 and CXCR4) expression in human myeloma cells: the association with disease activity and survival.
    Vande Broek I; Leleu X; Schots R; Facon T; Vanderkerken K; Van Camp B; Van Riet I
    Haematologica; 2006 Feb; 91(2):200-6. PubMed ID: 16461304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIF-2α Promotes Dissemination of Plasma Cells in Multiple Myeloma by Regulating CXCL12/CXCR4 and CCR1.
    Vandyke K; Zeissig MN; Hewett DR; Martin SK; Mrozik KM; Cheong CM; Diamond P; To LB; Gronthos S; Peet DJ; Croucher PI; Zannettino ACW
    Cancer Res; 2017 Oct; 77(20):5452-5463. PubMed ID: 28855206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple myeloma plasma cells show different chemokine receptor profiles at sites of disease activity.
    Trentin L; Miorin M; Facco M; Baesso I; Carraro S; Cabrelle A; Maschio N; Bortoli M; Binotto G; Piazza F; Adami F; Zambello R; Agostini C; Semenzato G
    Br J Haematol; 2007 Sep; 138(5):594-602. PubMed ID: 17686053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR4 is a good survival prognostic indicator in multiple myeloma patients.
    Bao L; Lai Y; Liu Y; Qin Y; Zhao X; Lu X; Jiang Q; Lu J; Huang X
    Leuk Res; 2013 Sep; 37(9):1083-8. PubMed ID: 23849988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalidomide treatment down-regulates SDF-1alpha and CXCR4 expression in multiple myeloma patients.
    Oliveira AM; Maria DA; Metzger M; Linardi C; Giorgi RR; Moura F; Martinez GA; Bydlowski SP; Novak EM
    Leuk Res; 2009 Jul; 33(7):970-3. PubMed ID: 18976811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatiotemporal CCR1, CCL3(MIP-1α), CXCR4, CXCL12(SDF-1α) expression patterns in a rat spinal cord injury model of posttraumatic neuropathic pain.
    Knerlich-Lukoschus F; von der Ropp-Brenner B; Lucius R; Mehdorn HM; Held-Feindt J
    J Neurosurg Spine; 2011 May; 14(5):583-97. PubMed ID: 21332278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potential of CCR1 antagonists for multiple myeloma.
    Karash AR; Gilchrist A
    Future Med Chem; 2011 Nov; 3(15):1889-908. PubMed ID: 22023033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the chemokine receptor CCR1 decreases sensitivity to bortezomib in multiple myeloma cell lines.
    Zeissig MN; Hewett DR; Mrozik KM; Panagopoulos V; Wallington-Gates CT; Spencer A; Dold SM; Engelhardt M; Vandyke K; Zannettino ACW
    Leuk Res; 2024 Apr; 139():107469. PubMed ID: 38479337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High CD6 and low chemokine receptor expression on peripheral blood lymphocytes correlates with MRI gadolinium enhancement in MS.
    Jurewicz A; Zaleski K; Domowicz M; Selmaj K
    J Neuroimmunol; 2014 Nov; 276(1-2):187-94. PubMed ID: 25242631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis.
    Katschke KJ; Rottman JB; Ruth JH; Qin S; Wu L; LaRosa G; Ponath P; Park CC; Pope RM; Koch AE
    Arthritis Rheum; 2001 May; 44(5):1022-32. PubMed ID: 11352233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine receptor expression in rat adjuvant-induced arthritis.
    Haas CS; Martinez RJ; Attia N; Haines GK; Campbell PL; Koch AE
    Arthritis Rheum; 2005 Dec; 52(12):3718-30. PubMed ID: 16320322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocrine regulation of re-epithelialization after wounding by chemokine receptors CCR1, CCR10, CXCR1, CXCR2, and CXCR3.
    Kroeze KL; Boink MA; Sampat-Sardjoepersad SC; Waaijman T; Scheper RJ; Gibbs S
    J Invest Dermatol; 2012 Jan; 132(1):216-25. PubMed ID: 21850025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A CCL chemokine-derived peptide (CDIP-2) exerts anti-inflammatory activity via CCR1, CCR2 and CCR3 chemokine receptors: Implications as a potential therapeutic treatment of asthma.
    Méndez-Enríquez E; Medina-Tamayo J; Soldevila G; Fortoul TI; Anton B; Flores-Romo L; García-Zepeda EA
    Int Immunopharmacol; 2014 May; 20(1):1-11. PubMed ID: 24560857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of CCL3 on osteoblast in myeloma bone disease].
    Zhao S; Fu R; Liu H; Wang Y; Li L; Liu C; Zhang T; Ding S; Gao S; Ruan E; Qu W; Wang H; Wang X; Wu Y; Song J; Liu H; Guan J; Shao Z
    Zhonghua Xue Ye Xue Za Zhi; 2014 Jul; 35(7):623-7. PubMed ID: 25052606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine-receptor upregulation and disease severity in respiratory syncytial virus infection.
    Morrison PT; Sharland M; Thomas LH; Manna S; Handforth J; Tibby S; Friedland JS
    Clin Immunol; 2008 Jul; 128(1):85-93. PubMed ID: 18439876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.
    Eltayeb S; Berg AL; Lassmann H; Wallström E; Nilsson M; Olsson T; Ericsson-Dahlstrand A; Sunnemark D
    J Neuroinflammation; 2007 May; 4():14. PubMed ID: 17484785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR1 and CCR2 antagonists.
    Zimmermann HW; Sterzer V; Sahin H
    Curr Top Med Chem; 2014; 14(13):1539-52. PubMed ID: 25159163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine receptor expression on the surface of peripheral blood mononuclear cells in Chagas disease.
    Talvani A; Rocha MO; Ribeiro AL; Correa-Oliveira R; Teixeira MM
    J Infect Dis; 2004 Jan; 189(2):214-20. PubMed ID: 14722885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CXCL12-3'A allele plays a favourable role in patients with multiple myeloma.
    Mazur G; Gębura K; Gieryng A; Butrym A; Wróbel T; Bogunia-Kubik K
    Cytokine; 2013 Oct; 64(1):422-6. PubMed ID: 23711392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.